Elyxium Wealth’s Johnson & Johnson JNJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$2.73M Buy
10,749
+3,472
+48% +$809K 0.29% 73
2026
Q1
$1.78M Buy
7,277
+300
+4% +$69.9K 0.57% 46
2025
Q4
$1.44M Sell
6,977
-96
-1% -$19K 0.4% 55
2025
Q3
$1.31M Buy
7,073
+854
+14% +$146K 0.46% 46
2025
Q2
$950K Buy
6,219
+799
+15% +$123K 0.36% 59
2025
Q1
$899K Buy
+5,420
New +$848K 0.4% 52
2024
Q4
Sell
-5,057
Closed -$820K 112
2024
Q3
$820K Buy
+5,057
New +$806K 0.45% 50

Other funds holding JNJ

Elyxium Wealth's JNJ Position: Q2 2026 in Review

Elyxium Wealth increased its Johnson & Johnson (JNJ) stake by 48% in Q2 2026, buying an estimated $809K and bringing the position to 10,749 shares worth $2.73M. The position accounts for 0.29% of the portfolio, ranked #73.

Elyxium Wealth first reported a position in JNJ in Q3 2024 and has held it in 7 quarters since. 4,677 funds tracked by Wall St. Rank hold JNJ as of Q2 2026.

  • Elyxium Wealth held 10,749 shares of Johnson & Johnson worth $2.73M as of Q2 2026.
  • Elyxium Wealth bought 3,472 Johnson & Johnson shares in Q2 2026, an estimated $809K.
  • Johnson & Johnson made up 0.29% of Elyxium Wealth's portfolio in Q2 2026, its #73 holding.
  • Elyxium Wealth first reported a position in Johnson & Johnson in Q3 2024 and has held it in 7 quarters since.
  • 4,677 funds tracked by Wall St. Rank held Johnson & Johnson as of Q2 2026.

Based on Elyxium Wealth's 13F filing for Q2 2026, filed 3 Aug 2026.